Skip to main content
SpringerLink
Log in

Psoriasis and Adherence to Therapy: Individual, Treatment-Related and General Factors

  • Chapter
  • First Online:
Book cover Adherence in Dermatology

Abstract

In the field of dermatology, psoriasis patients are more prone to therapy non-adherence. Patients’ perception of psoriasis, choice of medication and personal factors are some of the causes for therapy non-adherence. A positive physician-patient relationship is of paramount importance to achieve improved therapy adherence results and both have a responsibility. Doctors must be aware of pros and cons concerning medicine and patients economy. Early follow-up consultations are important to encourage patients’ treatment behaviour and to substitute medicine if necessary. Emails, daily text messages and app downloads are tools which can help the patients to remember their medicine (e.g. dosage, time intervals) and doctors consultations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zachariae R, Claus O, Zachariae C, Lei U, Pedersen AF (2008) Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 88:121–127

    Article  PubMed  Google Scholar 

  2. Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, Schäfer G, EUROPSO Patient Survey Group (2006) European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 155:729–736

    Article  CAS  PubMed  Google Scholar 

  3. Bewley A, Burrage DM, Ersser SJ, Hansen M, Ward C (2014) Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol 28:763–770

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Burroni AG, Fassino M, Torti A, Visentin E (2015) How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey. Patient Relat Outcome Meas 16:9–17

    Google Scholar 

  5. Feldman SR (2013) Disease burden and treatment adherence in psoriasis patients. Cutis 92:258–263

    PubMed  Google Scholar 

  6. Eastman WJ, Malahias S, Delconte J, DiBenedetti D (2014) Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis 94:46–53

    PubMed  Google Scholar 

  7. Puig L, Carrascosa JM, Belinchón I, Fernández-Redondo V, Carretero G, Ruiz-Carrascosa JC, Careaga JM, de la Cueva P, Gárate MT, Ribera M, Panel de Expertos del Consenso Delphi sobre Tratamiento tópico de la psoriasis, Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (2013) Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the psoriasis group of the Spanish Academy of dermatology and venereology. Actas Dermosifiliogr 104:488–496

    Article  CAS  PubMed  Google Scholar 

  8. Storm A, Andersen SE, Benfeldt E, Serup J (2008) One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 59:27–33

    Article  PubMed  Google Scholar 

  9. Storm A, Benfeldt E, Andersen SE, Serup J (2008) A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 59:975–980

    Article  PubMed  Google Scholar 

  10. Brown KK, Rehmus WE, Kimball AB (2006) Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 55:607–613

    Article  PubMed  Google Scholar 

  11. Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, Aractingi S, Aubin F, Bachelez H, Cribier B, Jullien D, Le Maître M, Richard MA, Ortonne JP, Paul C (2012) Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 26:61–67

    Article  PubMed  Google Scholar 

  12. Ulff E, Maroti M, Kettis-Lindblad A, Kjellgren KI, Ahlner J, Ring L, Serup J (2007) Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites. Br J Dermatol 156:974–978

    Article  CAS  PubMed  Google Scholar 

  13. Schaefer H, Redelmeier TE (1996) Skin barrier: principles of percutaneous absorption. Basel, Karger

    Google Scholar 

  14. Bronaugh RL, Maibach HI (2005) Percutaneous absorption, drugs-cosmetics-mechanisms-methodology, vol 55, 4th edn. Taylor and Francis Group, Boca Raton

    Book  Google Scholar 

  15. Ulff E, Maroti M, Serup J (2013) Fluorescent cream used as an educational intervention to improve the effectiveness of self-application by patients with atopic dermatitis. J Dermatolog Treat 24:268–271

    Article  PubMed  Google Scholar 

  16. Gartner L, Tarras-Wahlberg C (1984) A double-blind controlled evaluation of diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema. J Int Med Res 12:59–61

    CAS  PubMed  Google Scholar 

  17. Fouéré S, Adjadj L, Pawin H (2005) How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol 19:2–6

    Article  PubMed  Google Scholar 

  18. Halioua B, Maury Le Breton A, de Fontaubert A, Roussel ME, Stalder JF (2015) Treatment refusal among patients with psoriasis. J Dermatolog Treat 26:396–400

    Article  PubMed  Google Scholar 

  19. Finch T, Shim TN, Roberts L, Johnson O (2015) Treatment satisfaction among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol 8:26–30

    PubMed  PubMed Central  Google Scholar 

  20. Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Goerdt S, Peitsch WK (2015) Treatment satisfaction of patients with psoriasis. Acta Derm Venereol 95:572–578

    Article  PubMed  Google Scholar 

  21. Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A, Katoh N, Murota H, Takeuchi S, Sugaya M, Tanioka M, Kaneko S, Masuda K, Hiragun T, Inomata N, Kitami Y, Tsunemi Y, Abe S, Kobayashi M, Morisky DE, Furue M (2015) Poor adherence to medication as assessed by the Morisky medication adherence scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol 42:367–372

    Article  PubMed  Google Scholar 

  22. Roenigk HH (1994) Methotrexate. In: Dubertret L. Psoriasis (ed.). ISED Italy. pp 162–173

    Google Scholar 

  23. Inzinger M, Weger W, Heschl B, Salmhofer W, Quehenberger F, Wolf P (2013) Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions. J Eur Acad Dermatol Venereol 27:861–866

    Article  CAS  PubMed  Google Scholar 

  24. Zachariae C, Mørk NJ, Reunala T, Lorentzen H, Falk E, Karvonen SL, Johannesson A, Claréus B, Skov L, Mørk G, Walker S, Qvitzau S (2008) The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy. Acta Derm Venereol 88:495–501

    Article  CAS  PubMed  Google Scholar 

  25. Migliore A, Cusano F, Bianchi G, Malara G, Epis O, De Pità O (2015) Management of psoriatic arthritis: should the interaction between dermatologists and rheumatologists in clinical practice be intensified? J Biol Regul Homeost Agents 29:547–561

    CAS  PubMed  Google Scholar 

  26. Nikiphorou E, Negoescu A, Fitzpatrick JD, Goudie CT, Badcock A, Östör AJ, Malaviya AP (2014) Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. Clin Rheumatol 33:609–614

    Article  PubMed  Google Scholar 

  27. McHugh NJ (2015) Early psoriatic arthritis. Rheum Dis Clin North Am 41:615–622

    Article  PubMed  Google Scholar 

  28. You HS, Kim GW, Cho HH, Kim WJ, Mun JH, Song M, Kim HS, Ko HC, Kim MB, Lee SG, Lee IS, Kim BS (2015) Screening for psoriatic arthritis in Korean psoriasis patients using the psoriatic arthritis screening evaluation questionnaire. Ann Dermatol 27:265–268

    Article  PubMed  PubMed Central  Google Scholar 

  29. Roll A, Reich K, Boer A (2007) Use of fumaric acid esters in psoriasis. Indian J Dermatol Venereol Leprol 73:133–137

    Article  PubMed  Google Scholar 

  30. Ismail N, Collins P, Rogers S, Kirby B, Lally A (2014) Drug survival of fumaric acid esters for psoriasis: a retrospective study. Br J Dermatol 171:397–402

    Article  CAS  PubMed  Google Scholar 

  31. Swimberghe S, Ghislain PD, Daci E, Allewaert K, Denhaerynck K, Hermans C, Pacheco C, Vancayzeele S, MacDonald K, Abraham I (2013) Clinical, quality of life, patient adherence, and safety outcomes of short-course (12 weeks) treatment with cyclosporine in patients with severe psoriasis (the practice study). Ann Dermatol 25:28–35

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H, Barker J, Dauden E, de Jong EM, Feist E, Jacobs A, Jobling R, Kemény L, Maccarone M, Mrowietz U, Papp KA, Paul C, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Yawalkar N (2015) European S3-guidelines on the systemic treatment of psoriasis vulgaris – update 2015 – short version – EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 29:2277–2294

    Google Scholar 

  33. Poulin Y, Papp KA, Wasel NR et al (2010) A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol 49:1368–1375

    Article  PubMed  Google Scholar 

  34. DiBonaventura M, Wagner S, Waters H, Carter C (2010) Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis. J Drugs Dermatol 9:938–944

    PubMed  Google Scholar 

  35. Jones-Caballero M, Unaeze J, Penas PF, Stern RS (2007) Use of biological agents in patients with moderate to severe psoriasis: a cohort based perspective. Arch Dermatol 143:846–850

    Article  PubMed  Google Scholar 

  36. Mahler R, Jackson C, Ijacu H (2009) The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey. J Cutan Med Surg 13:283–293

    Article  PubMed  Google Scholar 

  37. Bhosle MJ, Feldman SR, Camacho FT, Whitmire TJ, Nahata MC, Balkrishnan R (2006) Medication adherence and health care costs associated with biologics in Medicaid- enrolled patients with psoriasis. J Dermatolog Treat 17:294–301

    Article  PubMed  Google Scholar 

  38. Gisondi P, Tessari G, Di Mercurio M et al (2013) Retention rate of systemic drugs in patients with chronic plaque psoriasis. Clin Dermatol 1:8–14

    Google Scholar 

  39. Ross C, Marshman G, Grillo M, Stanford T (2015) Biological therapies for psoriasis: adherence and outcome analysis from a clinical perspective. Australas J Dermatol (Epub ahead of print)

    Google Scholar 

  40. Drugs.com (visited 3 Dec 2015), searched titles: Ustekinumab, infliximab, adalimumab and etanercept

    Google Scholar 

  41. Zhang M, Brenneman SK, Carter CT, Essoi BL, Farahi K, Johnson MP, Lee S, Olson WH (2015) Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis. Patient Prefer Adherence 16(8):777–784

    Article  Google Scholar 

  42. Kalia S, Toosi B, Bansback N et al (2014) Assessing adherence with phototherapy protocols. J Am Acad Dermatol 71:1259–1261

    Article  PubMed  Google Scholar 

  43. Yentzer BA, Yelverton CB, Pearce DJ et al (2008) Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. J Am Acad Dermatol 59:577–581

    Article  PubMed  Google Scholar 

  44. Lings C, Kragballe K (2008) Klimabehandling til psoriasis (Eng: climatherapy for psoriasis), Århus Hospital, Denmark

    Google Scholar 

  45. Carroll CL, Feldman SR, Camacho FT, Balkrishnan R (2004) Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 151:895–897

    Article  CAS  PubMed  Google Scholar 

  46. Davis SA, Feldman SR (2013) Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol 149:490–491

    Article  PubMed  Google Scholar 

  47. Gelfand JM, Wang S, Takeshita J, Robertson AD et al (2013) Response to “Using Effects to Improve Adherence in Clinical Practice: Lessons from Clinical Trials”. JAMA Dermatol 149:490–491

    Article  Google Scholar 

  48. Cramer JA, Scheyer RD, Mattson RH (1990) Compliance declines between clinic visits. Arch Intern Med 150:1509–1510

    Article  CAS  PubMed  Google Scholar 

  49. Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R (2007) Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57:81–83

    Article  PubMed  Google Scholar 

  50. Davis SA, Lin HC, Yu CH, Balkrishnan R, Feldman SR (2014) Underuse of early follow-up visits: a missed opportunity to improve patients’ adherence. J Drugs Dermatol 13:833–836

    PubMed  Google Scholar 

  51. Balato N, Megna M, Di Costanzo L, Balato A, Ayala F (2013) Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol 168:201–205

    Article  CAS  PubMed  Google Scholar 

  52. Storm A, Benfeldt E, Andersen SE, Serup J (2009) Basic drug information given by physicians is deficient, and patients’ knowledge low. J Dermatolog Treat 20:190–193

    Article  PubMed  Google Scholar 

  53. Zschocke I, Mrowietz U, Karakasili E, Reich K (2014) Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol 28:4–9

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Bispebjerg University Hospital, Bispebjerg Bakke 23, DK-2400, Copenhagen, Denmark

    Katrina Hutton Carlsen & Jørgen Serup

  2. Department of Dermatology, University Hospital of Northern Norway, Tromsø, Norway

    Adel Olasz

  3. Centre for Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    Karen Marie Carlsen

Authors
  1. Katrina Hutton Carlsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adel Olasz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen Marie Carlsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jørgen Serup
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katrina Hutton Carlsen .

Editor information

Editors and Affiliations

  1. Eshelman Sch of Pharma, CB#7355, University of North Carolina, Chapel Hill, North Carolina, USA

    Scott A. Davis

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hutton Carlsen, K., Olasz, A., Carlsen, K.M., Serup, J. (2016). Psoriasis and Adherence to Therapy: Individual, Treatment-Related and General Factors. In: Davis, S. (eds) Adherence in Dermatology. Adis, Cham. https://doi.org/10.1007/978-3-319-30994-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30994-1_10

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-30992-7

  • Online ISBN: 978-3-319-30994-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation